510EGP
- Active ingredient
- fluticasone furoate+umeclindinium+vilanetrol
- Strength
- 100/62.5/25 mcg
- Form
- tablet
- Manufacturer
- mdi pharma
- Route
- oral.solid
Uses
Maintenance treatment of chronic obstructive pulmonary disease and selected patients requiring triple inhaled therapy.
Do not use if
Severe hypersensitivity to any component and use for acute bronchospasm.
Side effects
May cause nasopharyngitis, headache, cough, oral candidiasis, and upper respiratory tract infections.
Warnings
Not for acute symptom relief. Monitor for pneumonia and cardiovascular effects.
How it works
Combines an inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta2 agonist.
Storage
Store in original packaging and protect from moisture.
